AAP
POM

Arax Advisory Partners’s Pomdoctor Ltd POM Stock Holding History

Arax Advisory Partners’s Portfolio POM Stock Details POM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Buy
+722
New +$2.77K ﹤0.01% 4926

Other funds holding POM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Arax Advisory Partners's POM Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Pomdoctor Ltd (POM) in Q2 2026: 722 shares worth $1.05K. The stake represents ﹤0.01% of the portfolio and ranks #4926 among its holdings.

6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

  • Arax Advisory Partners held 722 shares of Pomdoctor Ltd worth $1.05K as of Q2 2026.
  • Pomdoctor Ltd was a new Arax Advisory Partners position in Q2 2026.
  • Pomdoctor Ltd made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4926 holding.
  • 6 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.